跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
EUG-BENDAMUSTINE bendamustine hydrochloride (as monohydrate) 100 mg powder for injection vial
Approved
STANDARD
EUG-BENDAMUSTINE bendamustine hydrochloride (as monohydrate) 100 mg powder for injection vial
Eugia Pharma (Australia) Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
9662daed3e1b0268
Company
Eugia Pharma (Australia) Pty Ltd
Type
Standard
Approval Details
Approval Id
9662daed3e1b0268
Product Name
EUG-BENDAMUSTINE bendamustine hydrochloride (as monohydrate) 100 mg powder for injection vial
Artg Id
426551
Artg Name
EUG-BENDAMUSTINE bendamustine hydrochloride (as monohydrate) 100 mg powder for injection vial
Sponsor
Eugia Pharma (Australia) Pty Ltd
Company Detail Path
/organization/eugia-pharma-australia-pty-ltd
Artg Date
2025-03-05
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
9662daed3e1b0268
Type
Standard
Back to TGA Approvals
EUG-BENDAMUSTINE bendamustine hydrochloride (as monohydrate) 100 mg powder for injection vial - TGA Drug Approval Details